| 311 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 312 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 313 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 314 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 315 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 316 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 317 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 318 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 319 |
Steroid/Antiviral for the treatment of Bell’s
palsy: Double blind randomized clinical trial |
2016 |
| 320 |
Steroid/Antiviral for the treatment of Bell’s
palsy: Double blind randomized clinical trial |
2016 |
Do you have any questions? 
